Company profile: Scandinavian ChemoTech
1.1 - Company Overview
Company description
- Provider of cancer care technologies, including IQwave – TSE (Tumour Specific Electroporation), a device and method that enhances uptake of cytotoxic drugs into tumor cells via electroporation, and D-EECT (Dynamic‑ElectroEnhanced ChemoTherapy), a treatment protocol aimed at better clinical outcomes for palliative patients with large tumor burdens.
Products and services
- Cancer Care Research & Clinical Trials: Develops innovation in cancer treatment through genuine research and clinical trials informed by founders’ surgical oncology and clinical development experience (clinical‑trial–driven)
- D-EECT (Dynamic-ElectroEnhanced ChemoTherapy): Architects a treatment protocol to deliver better clinical outcomes for palliative patients with large tumor burdens by dynamic electro‑enhancement of chemotherapy effectiveness (palliative‑focused)
- IQwave™ – TSE (Tumour Specific Electroporation): Engineers a device and method that improve uptake of cytotoxic drugs into tumor cells via electroporation across various cancers, applying the company’s patented know‑how (patented‑know‑how–based)
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Scandinavian ChemoTech
QSAM Biosciences
HQ: United States
Website
- Description: Provider of nuclear medicines for the treatment of cancer and related diseases and conditions.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full QSAM Biosciences company profile →
Delphinus Medical
HQ: United States
Website
- Description: Provider of breast cancer screening solutions for hospitals and imaging clinics, developing, commercializing, and servicing the SoftVue 3D Whole Breast Ultrasound Tomography, a 3D whole breast ultrasound system for dense breast screening that increases cancer detection by 20% when used alongside mammography.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Delphinus Medical company profile →
Medfusion Services
HQ: United States
Website
- Description: Provider of integrated clinical laboratory and clinical trial services, offering diagnostic testing (solid tumor, hematopathology, women's health, urology, general health), molecular diagnostics and test development, pathology services, and clinical trial support including specimen collection, processing, testing, and guidance for specimen packaging and shipping.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Medfusion Services company profile →
ESSA Pharma
HQ: Canada
Website
- Description: Provider of small molecule drugs for cancer treatment, with a focus on advanced prostate cancer, developing therapies that selectively block the N-terminal domain of the androgen receptor, a target required for the growth and survival of most prostate cancers.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full ESSA Pharma company profile →
Sofie
HQ: United States
Website
- Description: Provider of molecular imaging, focused on empowering people with new PET technologies.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Sofie company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Scandinavian ChemoTech
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Scandinavian ChemoTech
2.2 - Growth funds investing in similar companies to Scandinavian ChemoTech
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Scandinavian ChemoTech
4.2 - Public trading comparable groups for Scandinavian ChemoTech
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →